The stock's fall snapped a four-day winning streak.

Thermo Fisher Scientific has underperformed the broader market over the past year, but analysts are highly optimistic about ...

Detailed price information for Thermo Fisher Scientific Inc (TMO-N) from The Globe and Mail including charting and trades.

NVIDIA, Micron Technology and Thermo Fisher lead today's top analyst picks, each showing strong growth trends and strategic advances.

Thermo Fisher Scientific has cleared a major regulatory hurdle in getting a new diagnostic tool for a type of blood cancer in ...

Thermo Fisher Scientific (NYSE:TMO) has had a great run on the share market with its stock up by a significant 23% ...

Thermo Fisher’s Jennifer Cannon reviews the first year of the company’s Accelerator Drug Development suite of services and ...

Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the ...

Diamond Hill Capital, an investment management company, released its “Large Cap Fund” third-quarter 2025 investor letter. A ...

Thermo Fisher Scientific received 510 (k) clearance from the Food and Drug Administration to market its EXENT system to aid in the diagnosis of multiple myeloma. The company's EXENT system detects and ...

The new system addresses challenges around food and water quality testing in the face of contaminants such as per- and ...

Key Points Bought 18,686 shares; estimated trade size ~$8.70 million based on quarterly average price for Q3 2025 Transaction ...